United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2020_register executive 2020-11-11 article Notices D09002ee1c7b59a5d D09002ee1c7b59aea United States Federal Trade Commission originator org United States Government Agency or Subagency The consent agreement in this matter settles alleged violations of federal law prohibiting unfair methods of competition. The attached Analysis to Aid Public Comment describes both the allegations in the complaint and the terms of the consent order-- embodied in the consent agreement--that would settle these allegations. 85 FR 71895 https://www.govinfo.gov/app/details/FR-2020-11-12/2020-25021 2020-25021 fr12no20-41 6750-01-P File No. 191-0182 https://www.govinfo.gov/app/details/FR-2020-11-12/2020-25021 https://www.govinfo.gov/content/pkg/FR-2020-11-12/html/2020-25021.htm https://www.govinfo.gov/content/pkg/FR-2020-11-12/pdf/2020-25021.pdf 6 p. 71895 71900 85 FR 71895 Pfizer Inc. and Mylan N.V.; Analysis of Agreement Containing Consent Orders To Aid Public Comment; Federal Register Vol. 85, Issue NOTICE 2020-25021 FEDERAL TRADE COMMISSION 2020-12-14 File No. 191-0182 6750-01-P 2020-25021 Proposed consent agreement; request for comment.

The consent agreement in this matter settles alleged violations of federal law prohibiting unfair methods of competition. The attached Analysis to Aid Public Comment describes both the allegations in the complaint and the terms of the consent order-- embodied in the consent agreement--that would settle these allegations.

Comments must be received on or before December 14, 2020. Jasmine Rosner (202-326-3558), Bureau of Competition, Federal Trade Commission, 600 Pennsylvania Avenue NW, Washington, DC 20580. Proposed Consent Agreement: Pfizer, Inc. and Mylan NV, http://www.ftc.gov https://www.championforglobalhealth.com/media/championforglobalhealth/pdf/MylanUpjohnFactsheet072919.pdf https://www.championforglobalhealth.com/media/championforglobalhealth/pdf/mylanupjohninvestorpresentation072919.pdf https://www.fiercepharma.com/marketing/mylan-and-pfizer-debuts-new-viatris-generics-merged-brandunveils-tri-color-logo-for https://www.ftc.gov/news-events/commission-actions https://www.ftc.gov/site-information/privacy-policy https://www.ftc.gov/system/files/documents/public_statements/1418711/162_3197_statement_of_commissioner_chopra_on_sofi_10-29-18.pdf https://www.ftc.gov/system/files/documents/public_statements/1554278/bms-celgene-wilson-statement.pdf https://www.ftc.gov/system/files/documents/public_statements/1574583/191_0169_dissenting_statement_of_commissioner_rohit_chopra_in_the_matter_of_abbvie-allergan_redacted.pdf https://www.justice.gov/opa/pr/seventh-generic-drug-manufacturer-charged-ongoing-criminal-antitrustinvestigation https://www.justice.gov/sites/default/files/atr/legacy/2010/08/19/hmg-2010.pdf https://www.pfizer.com/news/pressrelease/pressreleasedetail/mylan_and_upjohn_a_division_of_pfizer_to_combine_creating_a_new_champion_for_global_health_uniquely_positioned https://www.regulations.gov Vol. 85, no. 219 Office of the Federal Register, National Archives and Records Administration 2020-11-12 continuing daily deposited born digital 741 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2020-11-12 P0b002ee1a9430a83 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr12no20 https://www.govinfo.gov/app/details/FR-2020-11-12 https://www.govinfo.gov/content/pkg/FR-2020-11-12/pdf/FR-2020-11-12.pdf https://www.govinfo.gov/content/pkg/FR-2020-11-12/xml/FR-2020-11-12.xml fdlp 71815 72550 DGPO 2020-11-11 2024-05-30 FR-2020-11-12 machine generated eng FR FR-2020-11-12 85 219